93 journalists killed in 2016; 29 more die in accidents

December 31, 2016

Brussels, Dec 31: The International Federation of Journalists says that 93 journalists and media staff were killed in targeted attacks, by bombs or by crossfire in 2016 while a further 29 died in two plane crashes.

The IFJ said in its annual report released today that the number was down from 112 in 2015. Iraq still had the largest number of media killings with 15, ahead of Afghanistan with 13 and Mexico with 11.

Despite the slight decrease in deadly violence against journalists, IFJ President Philippe Leruth said that the statistics "give little room for comfort nor ground for hope to see the end of the current media safety crisis."

In the two plane crashes, 20 Brazilian journalists died in Colombia and nine Russian media staff died as they headed to Syria.

Comments

Add new comment

Coastaldigest.com reserves the right to delete or block any comments.
Coastaldigset.com is not responsible for its readers’ comments.
Comments that are abusive, incendiary or irrelevant are strictly prohibited.
Please use a genuine email ID and provide your name to avoid reject.

AstraZeneca to withdraw Covid-19 vaccine globally as demand dips after admitting side effects

News Network

May 8,2024

AstraZeneca said on Tuesday it had initiated the worldwide withdrawal of its COVID-19 vaccine due to a "surplus of available updated vaccines" since the pandemic.

The company also said it would proceed to withdraw the vaccine Vaxzevria's marketing authorizations within Europe.

"As multiple, variant Covid-19 vaccines have since been developed there is a surplus of available updated vaccines," the company said, adding that this had led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied.

According to media reports, the Anglo-Swedish drugmaker has previously admitted in court documents that the vaccine causes side-effects such as blood clots and low blood platelet counts.

The firm's application to withdraw the vaccine was made on March 5 and came into effect on May 7, according to the Telegraph, which first reported the development.

London-listed AstraZeneca began moving into respiratory syncytial virus vaccines and obesity drugs through several deals last year after a slowdown in growth as COVID-19 medicine sales declined.

Comments